To assess possible cancer cell type-specific methylation, we conducted a cell type specific subanalysis examining of the 98 internally and the 5 externally validated sites from the main analysis in a squamous cell carcinoma-only (n = 243) and adenocarcinoma-only (n = 268) model.
, external p-value = 0.016). The squamous cell carcinomaonly sub-analysis also showed similar results compared to the main analysis with changes in the effect magnitude. From the internally validation analysis, the strongest statistically significant CpG site was cg16200496 (NFIX; beta = −1.20, pooled p-value = 6.57 × 10 −10
, external p-value = 0.27) (Supplementary Table S3 ). We noted that the external validation for squamous cell carcinomaonly analyses was not stable due to the limited sample size. Furthermore, there were no cases with EGFR or KRAS mutations in the squamous cell restricted analysis.
We investigated dose-response relationship for the five externally validated CpG sites (Supplementary Figure S1) . Descriptions of trend and statistical significance were provided in Supplementary Figure S1 . Briefly, the directionality of effect estimate is identical between dose-response relationships in LUAD and LUSC. However, the effect estimate was statistically significantly stronger in LUSC except for cg22515201 (Supplementary Figure S1E and S1F) compared to the same sites in LUAD suggesting differential mechanistic processes in this cell type. Cigarette smoking explained the most variation of cg16200496 in LUSC (R 2 = 0.144). Similarly to the main analysis, R 2 values of other CpG sites were consistently low, suggesting that epigenetic variation is not adequately explained by smoking alone. Higher smoking pack-years are associated with strongly decreased M-values (p = 7.52E-30). The trend line suggests higher smoking exposure levels impose negative effects on M-values. The multivariate linear regression model restricted to squamous cell cases adjusting for smoking status and all confounding covariates explains only some of the total variability in methylation at this site (R 2 = 0.17).
Supplementary

Supplementary Figure S1E:
Smoking and methylation dose-response at cg22515201 in PLA2G6 for Adenocarcinomaonly cases. There appears to be a highly significant, negative dose-response relationship between pack-years and M-values. Higher smoking pack-years are associated with strongly decreased M-values (p = 1.64E-17). The trend line suggests higher smoking exposure levels impose negative effects on M-values. The multivariate linear regression model restricted to adenocarcinoma cases adjusting for smoking status and all confounding covariates explains only some of the total variability in methylation at this site (R 2 = 0.23).
